Clinical Trials Browser

Phase 1 × Pancreatic Neoplasms × fluzoparib × Clear all

NCT04425876 2020-12-31

A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Resectable Pancreatic Cancer

Phase 1 Unknown

Gastrointestinal

Pancreatic Neoplasms